• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Resverlogix Corp

+ Add to Watchlist

RVXCF:US

0.4158 USD 0.0068 1.66%

As of 20:10:01 ET on 12/26/2014.

Snapshot for Resverlogix Corp (RVXCF)

Open: 0.4090 Day's Range: 0.4090 - 0.4158 Volume: 1,030
Previous Close: 0.4090 52wk Range: 0.3500 - 0.8120 1-Yr Rtn: -15.23%

Stock Chart for RVXCF

No chart data available.
  • RVXCF:US 0.4158
  • 1D
  • 1M
  • 1Y
0.4090
Interactive RVXCF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RVXCF

Current P/E Ratio (ttm) -
Estimated P/E(04/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (04/2015) -0.1410
Est. PEG Ratio -
Market Cap (M USD) 35.49
Shares Outstanding (M) 85.36
30 Day Average Volume 8,681
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RVXCF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RVXCF

Resverlogix Corp. is a biotechnology company focused on developing therapies for unmet medical needs. The Company concentrates on cardiovascular disease, cancer, and fibrotic conditions.

Donald J McCaffreyPresident/CEO/SecretaryAaron Bradley Cann "Brad"Chief Financial Officer
Norman WongChief Scientific OfficerKenneth LebiodaSenior VP:Bus & Corporate Dev
More Company Profile & Key Executives for RVXCF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil